![Prescription transparency](https://portal.ct.gov/ohs/-/media/ohs-beta/site-images/prescription-drug-cost-transparency/prescription-drug.jpg?rev=680ff1e44ecb4cc2ac0d7d2921471512&sc_lang=en&h=400&w=600&la=en&hash=9E20E9230F97182ADABEF1DE497C84E5)
Program overview
Connecticut, like other states, has a prescription drug cost transparency program. Prescription transparency requires drug manufacturers, pharmacy benefit managers, health plans, and others to report information that explains high price increases and high-priced new drugs.
The laws focus on a list of 10 outpatient prescription drugs determined by the Office of Health Strategy (OHS) as:
The laws focus on a list of 10 outpatient prescription drugs determined by the Office of Health Strategy (OHS) as:
- A substantial cost to the state or
- Critical to public health